East Genomics
Viewing more quick links
-
Test Directory Update Rare & Inherited Diseases
Tests have been added, changed and removed. Notable updates include addition of cardiology test R454 for Mavacamten prescribing, and include changes affecting developmental disorder, neurology and inherited cancers. Removed tests include R53 fragile X and array tests where WGS is available.
Check details
-
New test available CYP2C19 for Mavacamten
Genetic testing of CYP2C19 to assess suitability for Mavacamten treatment of symptomatic obstructive hypertrophic cardiomyopathy should now be ordered through the GMS. Test R454 has special ordering requirements.
Find out how to order
-
Our genomics e-learning website launch
Register an account to take modules on patient choice, hereditary breast cancer, inherited cardiac conditions, carrier testing in primary care, rapid prenatal exome sequencing and more...
Our new genomics e-learning platform launched
-
Updates, events, training.
Newsletters and test updates